CARsgen Therapeutics (HKG:2171) released 2,667,000 options to 31 grantees under its post-initial public offering share option scheme, according to a Tuesday filing with the Hong Kong Exchange.

The options represent 2,667,000 shares with an exercise price of HK$7.26 per share, the filing said.

Director Hua Jiang will receive 200,000 options while the rest of the employees will get an aggregate of 2,467,000 options, the filing said.